N/A
Manufactured by Haleon US Holdings LLC
15,305 FDA adverse event reports analyzed
Last updated: 2026-04-15
ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Haleon US Holdings LLC. The most commonly reported adverse reactions for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE include CHRONIC KIDNEY DISEASE, DIARRHOEA, ACUTE KIDNEY INJURY, NAUSEA, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE.
Out of 6,575 classified reports for ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 15,305 FDA FAERS reports that mention ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include CHRONIC KIDNEY DISEASE, DIARRHOEA, ACUTE KIDNEY INJURY, NAUSEA, VOMITING, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Haleon US Holdings LLC in connection with ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE. Always verify the specific product and NDC with your pharmacist.